1Perez L,Zulueta O,Melchor A,et al.Purification of human prostatic-specific antigen(hPSA) from seminal plasma by immunoaffinity chromatography using a monoclonal antibody anti total PSA[J].Hybridoma (Larchmt),2011,30 (3):247-251.
2Ding W,Lee J,Chamberlain D,et al.Twelve-month prostate specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy[J].Int J Radiat Oncol Biol Phys,2012,84(4):962-967.
3Oberaigner W,Horninger W,Klocker H,et al.Reduction of prostate cancer mortality in Tyrol,Austria,after introduction of prostate-specific antigen testing[J].Am J Epidemiol,2006,164(4):376-384.
4Mikel H J,Boorjian SA,Frank I,et al.The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes[J].Urol Oncol,2013.
5Jaeger CD,Krambeck AE.Holmium Laser Enucleation of the Prostate for Persistent Lower Urinary Tract Symptoms After Prior Benign Prostatic Hyperplasia Surgery[J].Urology,2013.
6Carvalhal GF,Smith DS,Mager DE,et al.Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml.or less[J].J Urol,1999,161 (3):835-839.
7Eastham JA,May R,Robertson JL,et al.Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL[J].Urology,1999,54(4):709-713.
9Legrys V A,Funk M J,Lorenz C E,et al.Subclinical Hypothyroidism and Risk for Incident Myocardial Infarction Among Postmenopausal Women[J].J Clin Endocrinol Metab,2013.
2[1]Oesterling JE, Jacobetn ST, Klee GG, et al. J Urol, 1995;154: 755.
3[2]Benson MC. Ohalng IS. Pantuck A, et al. J Urol, 1992; 147: 815.
4[3]Seaman EK, Whang IS, OLsson CA, et al. Urology 1994; 43; 645.
5[4]Catalona WT, Smith DS. Ratliff TL, J Urol, 1993; 149: 300A.
6Stenman U H, Leininen J, Alfthan H, et al. A complex between prostate specific antigen and alpha 1-antichy-motrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer [J].Cancer-Res, 1991,51 ( 1 ) :222-226.
7Higashihara E, Nutahara K, Kojima M, et al. Significance of serum free prostate specific antigen in the screening of prostate cancer[J]. J Urol,1996,156(6):1964-1968.
8Stephan C, Lein M, Jung K, et al. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benigh prostate hyperplasia[J]. Cancer,1997,79(1) :104-109.
9Catalona W J, Smith D S,Wolfert R L,et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening[J]. JAMA,1995,274(15):1214-1220.
10Benson M C, Whang L S, Pantuek A, et al. prostate specific antigen density: a means of distinguishing benign prostatic by pertrophy and prostate cancer[J]. J Urol,1992, 147(3PTZ) :815-816.
1Allemani, C., et al., Global surveillance of cancer survival 1995-2009:analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)[S]. Lancet, 2014.
2Mikel Hubanks, J. et al. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes[J]. Urol Oncol, 2014, 32(1):26-27.
